SG155193A1 - Novel product, method and intermediates for the preparation of azetidine derivatives - Google Patents

Novel product, method and intermediates for the preparation of azetidine derivatives

Info

Publication number
SG155193A1
SG155193A1 SG200905236-6A SG2009052366A SG155193A1 SG 155193 A1 SG155193 A1 SG 155193A1 SG 2009052366 A SG2009052366 A SG 2009052366A SG 155193 A1 SG155193 A1 SG 155193A1
Authority
SG
Singapore
Prior art keywords
intermediates
preparation
novel product
azetidine derivatives
azetidine
Prior art date
Application number
SG200905236-6A
Other languages
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Luc Grondard
Joel Malpart
Joerg Rieke-Zapp
Veronique Crocq
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SG155193A1 publication Critical patent/SG155193A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG200905236-6A 2004-10-14 2005-10-10 Novel product, method and intermediates for the preparation of azetidine derivatives SG155193A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
SG155193A1 true SG155193A1 (en) 2009-09-30

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200905236-6A SG155193A1 (en) 2004-10-14 2005-10-10 Novel product, method and intermediates for the preparation of azetidine derivatives

Country Status (21)

Country Link
US (1) US7687493B2 (pt)
EP (1) EP1805167A2 (pt)
JP (1) JP2008516932A (pt)
KR (1) KR20070063544A (pt)
CN (1) CN101039931A (pt)
AR (1) AR051390A1 (pt)
AU (1) AU2005293454A1 (pt)
BR (1) BRPI0516507A (pt)
CA (1) CA2583992A1 (pt)
EA (1) EA011408B1 (pt)
EC (1) ECSP077332A (pt)
FR (1) FR2876688B1 (pt)
IL (1) IL181904A0 (pt)
MA (1) MA29513B1 (pt)
MX (1) MX2007003923A (pt)
NO (1) NO20072192L (pt)
SG (1) SG155193A1 (pt)
TN (1) TNSN07097A1 (pt)
TW (1) TW200630358A (pt)
WO (1) WO2006040465A2 (pt)
ZA (1) ZA200702528B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
JP4101053B2 (ja) * 2000-08-10 2008-06-11 田辺三菱製薬株式会社 プロリン誘導体及びその医薬用途
US7825109B2 (en) * 2003-08-29 2010-11-02 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof

Also Published As

Publication number Publication date
IL181904A0 (en) 2007-07-04
TW200630358A (en) 2006-09-01
BRPI0516507A (pt) 2008-09-16
JP2008516932A (ja) 2008-05-22
WO2006040465A2 (fr) 2006-04-20
MA29513B1 (fr) 2008-06-02
WO2006040465A3 (fr) 2006-08-10
US20070270463A1 (en) 2007-11-22
US7687493B2 (en) 2010-03-30
FR2876688B1 (fr) 2007-03-16
AU2005293454A1 (en) 2006-04-20
EP1805167A2 (fr) 2007-07-11
EA011408B1 (ru) 2009-02-27
ECSP077332A (es) 2007-04-26
ZA200702528B (en) 2008-07-30
CN101039931A (zh) 2007-09-19
CA2583992A1 (fr) 2006-04-20
FR2876688A1 (fr) 2006-04-21
NO20072192L (no) 2007-04-27
EA200700840A1 (ru) 2007-08-31
AR051390A1 (es) 2007-01-10
MX2007003923A (es) 2007-06-07
KR20070063544A (ko) 2007-06-19
TNSN07097A1 (fr) 2008-06-02

Similar Documents

Publication Publication Date Title
HUP0400405A3 (en) Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
PT2638891E (pt) Método para a produção de produtos farmacêuticos
IL180252A0 (en) Intermediates for the preparation of halichondrin b
IL180290A0 (en) Process for production of azulene derivatives and intermediates for the synthesis of the same
IL179758A0 (en) Substituted tetrahydro - 2h - isoquinolin - 1 - one derivatives, method for the production thereof, and use of the same as medicaments
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
SI2044099T1 (sl) Postopek priprave S-fluorometil-6,9-difluoro-11-hidroksi-16-metil-17-propioniloksi-3-okso -androsta-1,4-dien-17-karbotioata in vmesnih spojin
LT1928255T (lt) Pieno produktų gamybos būdas, tuo būdu gauti produktai ir jų panaudojimas
ZA200704189B (en) Method for the manufacture of extended steel products
PL366690A1 (en) New derivatives of 4,5,6,7-tetrabromobenzimidazole and method for their obtaining
IL182277A0 (en) Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
IL181904A0 (en) Novel product, method and intermediates for the preparation of azetidine derivatives
IL181339A0 (en) Method for the production of diarylcycloalkyl derivatives
IL182445A0 (en) Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide
HUP0401379A3 (en) Process for the preparation of risperidon
SI1622926T1 (sl) Nov postopek in intermediati za pripravo 17-halogen-19-nor-steroidnih spojin
GB2433504B (en) Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof
AU2004901802A0 (en) Process for the preparation of intermediates
TWI365874B (en) One-pot process for the preparation of 1,2-benz-isoxazole-3-methanesulfonamide
IL179724A0 (en) Method for producing acetamidopyrrolidine derivatives and novel benzamidoacetic acid derivatives as intermediates therefor
HU0401267D0 (en) New intermediates and process for producing them
HK1109135A (en) Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
HK1107332A (en) Process for the preparation of intermediates
PL363252A1 (en) New derivative of pyrol-3,4- dicarboxy-imide and method for its production
AU2004903098A0 (en) Method of, and apparatus for, the manufacture of cornices